DK0673376T3 - Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem - Google Patents

Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem

Info

Publication number
DK0673376T3
DK0673376T3 DK94902003.6T DK94902003T DK0673376T3 DK 0673376 T3 DK0673376 T3 DK 0673376T3 DK 94902003 T DK94902003 T DK 94902003T DK 0673376 T3 DK0673376 T3 DK 0673376T3
Authority
DK
Denmark
Prior art keywords
pct
processes
preparation
pyrimidine compounds
pharmaceutical agents
Prior art date
Application number
DK94902003.6T
Other languages
Danish (da)
English (en)
Inventor
Gilbert Regnier
Alain Dhainaut
Ghanem Atassi
Alain Pierre
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0673376T3 publication Critical patent/DK0673376T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94902003.6T 1992-12-11 1993-12-09 Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem DK0673376T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9214913A FR2699176B1 (fr) 1992-12-11 1992-12-11 Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
DK0673376T3 true DK0673376T3 (da) 1996-10-07

Family

ID=9436453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94902003.6T DK0673376T3 (da) 1992-12-11 1993-12-09 Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem

Country Status (13)

Country Link
US (1) US5508277A (de)
EP (1) EP0673376B1 (de)
JP (1) JPH08504426A (de)
AT (1) ATE138380T1 (de)
AU (1) AU666422B2 (de)
CA (1) CA2117462A1 (de)
DE (1) DE69302829T2 (de)
DK (1) DK0673376T3 (de)
ES (1) ES2091126T3 (de)
FR (1) FR2699176B1 (de)
GR (1) GR3020330T3 (de)
NZ (1) NZ258595A (de)
WO (1) WO1994013668A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9110772U1 (de) * 1991-08-30 1991-11-14 Wolf - Geräte GmbH Vertriebsgesellschaft KG, 5240 Betzdorf Gartenschere
FR2699176B1 (fr) * 1992-12-11 1995-03-03 Adir Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US6794390B2 (en) * 1996-08-02 2004-09-21 Cv Therapeutics, Inc. Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
EP2671507A3 (de) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-Informatiksystem
EP1915377A1 (de) 2005-07-22 2008-04-30 Sunesis Pharmaceuticals, Inc. Als aurorakinaseinhibitoren geeignete pyrazolpyrimidine
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
TW201100427A (en) 2009-03-31 2011-01-01 Arqule Inc Substituted heterocyclic compounds
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20250213546A1 (en) * 2022-04-01 2025-07-03 Drexel University Treating cancer with small molecules that inhibit acss-2

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544419A (en) * 1975-11-19 1979-04-19 Science Union & Cie Purines and pyrazolo-pyrimidines a process for their preparation and pharmaceutical compositions containing them
DE2804416A1 (de) * 1978-02-02 1979-08-09 Boehringer Mannheim Gmbh Neue purin-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
CA1338625C (en) * 1988-06-09 1996-10-01 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
EP0363320A3 (de) * 1988-10-06 1991-11-21 Ciba-Geigy Ag Substituierte 9H-Purine
FR2643373B1 (fr) * 1989-01-10 1993-12-31 Adir Cie Nouveaux derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US5256650A (en) * 1989-03-29 1993-10-26 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
EP0514540B1 (de) * 1989-09-19 1996-07-17 Teijin Limited Pyrrolo[2,3-d]pyrimidinderivate, verfahren zur herstellung und arzneimittelzusammensetzungen die diese enthalten
JP2541702B2 (ja) * 1989-10-11 1996-10-09 帝人株式会社 二環性ピリミジン誘導体、その製造方法およびそれを有効成分とする医薬製剤
US5397782A (en) * 1990-06-13 1995-03-14 Janssen Pharmaceutica N.V. Method of treating addiction to alcohol
US5217980A (en) * 1990-07-19 1993-06-08 Janssen Pharmaceutica N.V. Oxazolyl and piperidinyl substituted benimidazolyl compounds
DE69028994T2 (de) * 1990-12-06 1997-04-10 Sony Corp., Tokio/Tokyo Rückgekoppelte klemmschaltung
FR2699176B1 (fr) * 1992-12-11 1995-03-03 Adir Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
GR3020330T3 (en) 1996-09-30
US5508277A (en) 1996-04-16
AU5653594A (en) 1994-07-04
ATE138380T1 (de) 1996-06-15
CA2117462A1 (fr) 1994-06-23
FR2699176B1 (fr) 1995-03-03
WO1994013668A1 (fr) 1994-06-23
DE69302829T2 (de) 1996-11-28
ES2091126T3 (es) 1996-10-16
EP0673376B1 (de) 1996-05-22
DE69302829D1 (de) 1996-06-27
JPH08504426A (ja) 1996-05-14
NZ258595A (en) 1996-04-26
FR2699176A1 (fr) 1994-06-17
EP0673376A1 (de) 1995-09-27
AU666422B2 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
DE69104723D1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
SE0202463D0 (sv) Novel compounds
SE9904505D0 (sv) Novel compounds
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
DE59610077D1 (de) Phenyldihydrobenzofurane
DK0673376T3 (da) Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem
DK0783501T3 (da) Pyrimidonderivater med anti-fungal aktivitet
NO993027D0 (no) Pyrrolo[3,4-D]pyrimidinonderivater og deres anvendelse som legemidler
ATE230404T1 (de) Cyclohexyldihydrobenzofurane
MY128896A (en) Pharmaceutical combinations
DE69219901D1 (de) Adenosinderivate, Verfahren zu deren Herstellung und pharmazeutische Mittel
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
MXPA02006250A (es) Derivados de butino diol.
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
ATE169021T1 (de) Cephalostatin-analoga und ihre verwendung als antitumormittel
ZA9427B (en) Use of riluzole for promoting restoration following radiation
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
MX9710277A (es) Derivados de purina sustituidos, procedimientos para su preparacion, su utiliazacion y agentes que los contienen.